STRATEGIC PARTNERSHIPS

Unlocking the power of AmberFlow     single cell platform technology while leveraging our team’s ample experiences in immuno-discovery and deep understanding of single cell assay biology, we welcome synergistic partnerships in discovering next-generation therapeutic biologics for difficult targets including those that require a unique mode-of-action and/or functional property, which are otherwise challenging for conventional approaches.

TM

© 2019 Amberstone Biosciences